Report Overview

According to the deep-dive market assessment study by Growth Plus Reports, the global biliary stents market was pegged at US$ 358.26 million in 2021 and is expected to register a CAGR of 4.86% to reach US$ 549.14 million by 2030. 

Market Fundamentals 

The biliary stent is a flexible metallic tube created to keep blocked or partially blocked bile duct open. Fluids like bile juice necessary for digestion cannot enter the intestine when the bile duct is blocked. The liver secretes bile into the intestinal channel through the bile duct, which opens in the gut, and bile plays a crucial role in the digestion of food. Biliary stents are stents used to treat biliary diseases. Placement of a biliary stent is utilized for conditions such as drainage of a benign or malignant biliary obstruction, dilated biliary strictures, and bile leakage. Many people utilize biliary stenting to treat benign biliary disorders or to relieve the symptoms of malignant blockage.

[76583534]

Market Dynamics

Factors expected to propel the global market revenue for biliary stents owing to the rise in surgical operations for biliary-related disorders brought on by aging and inactivity. The market revenue growth is being produced by rising public awareness and a surge in demand for efficient post-operative care. Additionally, the demand for biliary stents has increased as a result of increased disposable income, which is leading to higher standards of life and the expansion of the biliary stents market revenue. Another significant factor driving the global biliary stents market revenue expansion is the increase in urbanization. Also, the accuracy level of the Endoscopic retrograde cholangiopancreatography (ERCP) test has been surpassed by technological improvements and efficient diagnostic techniques. The demand for using biliary stents, a minimally invasive procedure, is growing as more people are using them. Longer hospital stays, fewer infections and faster recovery times are just a few advantages of the growing technological advancements in the detection and treatment of gastrointestinal problems, including bile duct obstruction. Thus, the need for biliary stents is growing exponentially. 

However, post-operative problems and strict government regulations are two factors limiting the market revenue expansion. As a result of recent technological advancements, biodegradable stents that do not need to be removed are far less expensive to maintain following surgery.

Market Ecosystem

The global biliary stents market has been analyzed from four perspectives: type, application, end-user, and region.

Biliary Stents Market by Type 

Based on type, the global biliary stents market is segmented into metal and polymer. 

The metal biliary stents segment dominates the global market with the fastest CAGR.  Over the past 30 years, biliary stenting has undergone several advancements. Patients with benign or malignant biliary tract illnesses can now receive their primary treatment therapy for blockage relief with endoscopic stent insertion. Due to a bigger lumen and longer stent patency than plastic stents, self-expandable metallic stents have been used to treat patients with malignant strictures. Metal stents have recently been employed for several benign biliary strictures and leaks. It comes in a wide range of lengths and diameters and resembles mesh-like tubes of thin wires. The post-expansion diameter of the self-expanding metal stents ranges from 6 to 10 mm. The prevalence of bile duct-related disorders such as biliary leakage, pancreatic cancer, and other malignant obstructions like gallstones that cause bile duct blockage are some of the main factors driving the use of metal stents. Plastic biliary stents can be used alone or with an introducer or pusher catheter.

Biliary Stents Market by Application

[2423535]

Based on applications, the global biliary stents market is segmented into bilio-pancreatic leakages, malignant obstruction, benign biliary structures, and gallstones. 

The gallstone segment accounts for the largest revenue share in the global biliary stents market. A family history of gallstones and lifestyle changes such as adopting an unhealthy, sedentary lifestyle are identified to be some of the significant factors contributing to the increased occurrence of gallstones. Gallstones are one of the most prevalent biliary system illnesses and are considered non-fatal. On the other hand, due to the increasing incidence of cancer, acute bile duct diseases, and the lack of alternatives to biliary stent implantation, the malignant obstruction and benign biliary strictures market segments are expected to rise significantly during the forecast period.

Biliary Stents Market by End User

Based on end users, the global biliary stents market is segmented into hospitals, specialty clinics, & ambulatory surgical centers. 

The ambulatory surgical center segment accounts for the highest revenue share. Ambulatory care is in increased demand in developed and some developing nations due to the benefits it offers, including reduced costs, quick recovery, and decreased infection rates, as well as the growing preference for minimally invasive procedures. Additionally, to draw in a larger client base, the usage of biliary stents and associated treatments must increase.

Biliary Stents Market by Region

Based on the region, the biliary stents market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. 

North America dominates the global market in terms of the largest revenue share. Strong health infrastructure in the area makes it easier for residents of the country to receive hospital services. Additionally, as more and more people have access to medical insurance, the number of super-specialty treatments available to treat the disease is growing. The business is also getting a boost from current research on biodegradable stents. 

Similarly, the European region also has easily accessible medical facilities and a high prevalence of the senior population, which are expected to raise the market's need for stents. The demand for biliary stents in the market is anticipated to rise as medical facilities are developed in the Asia Pacific region, the proportion of the elderly population rises, and young people lead more sedentary lifestyles.

Competitive Landscape

The key companies operating in the global biliary stents market are:

• Boston Medical Products
• B. Braun Melsungen AG
• Cook Medical Inc.
• Olympus Corporation
• CONMED Corporation
• M.I. Tech
• Becton, Dickinson, and Company
• ENDO-FLEX GmbH
• Cardinal Health
• Merit Medical Systems, Inc.
• Eckert & Ziegler BEBIG S.A.
• Medtronic plc
• Cook Medical Inc

Strategic Development

• In October 2021, Boston Scientific declared that its Advanix biliary plastic stents now have the CE Mark and 510(k) clearance from the U.S. Food and Drug Administration. The clearance will expand the company's product line, boosting sales for the business.
• In October 2020, The StoneMasterV gadget and VorticCatchV Endo Therapy were introduced by Olympus Corporation. These tools enhance procedural effectiveness and improve patient outcomes, making it easier to control and remove bile duct stones for ERCP procedures. The new launch sought to broaden the company's product line and strengthen its market position.

Frequently Asked Questions About This Report